BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 426585)

  • 1. Effect of early plasmapheresis and immunosuppressive therapy on natural history of anti-glomerular basement membrane glomerulonephritis: report of a 22-month follow-up.
    Bruns FJ; Stachura I; Adler S; Segel DP
    Arch Intern Med; 1979 Mar; 139(3):372-4. PubMed ID: 426585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery from rapidly progressive glomerulonephritis. Improvement after plasmapheresis and immunosuppression.
    Warren SE; Mitas JA; Golbus SM; Swerdlin AR; Cohen IM; Cronin RE
    Arch Intern Med; 1981 Feb; 141(2):175-80. PubMed ID: 7006545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of initial histology and effect of plasmapheresis on long-term prognosis of rapidly progressive glomerulonephritis.
    Zäuner I; Bach D; Braun N; Krämer BK; Fünfstück R; Helmchen U; Schollmeyer P; Böhler J
    Am J Kidney Dis; 2002 Jan; 39(1):28-35. PubMed ID: 11774098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-basement-membrane antibody mediated, rapidly progressive, glomerulonephritis. Diagnostic and therapeutic strategy based on a retrospective study of 14 cases].
    Bouget J; Le Pogamp P; Perrier G; Ramée MP; Rivalan J; Camus C; Thomas R; Chevet D
    Ann Med Interne (Paris); 1990; 141(5):409-15. PubMed ID: 2256583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid progressive glomerulonephritis: relapse after prolonged remission.
    Adler S; Bruns FJ; Fraley DS; Segel DP
    Arch Intern Med; 1981 Jun; 141(7):852-4. PubMed ID: 7235804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rapidly progressive glomerular disease treated with plasmapheresis (author's transl)].
    Praga M; Mijares R; Elósegui A; de los Mozos J; Ochoa de Olza M; Cortabitarte N; López de Novales E
    Med Clin (Barc); 1981 Jun; 77(1):33-6. PubMed ID: 7253760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of plasma exchange and immunosuppression to improve renal function in Goodpasture's syndrome.
    McLeish KR; Maxwell DR; Luft FC
    Clin Nephrol; 1978 Aug; 10(2):71-3. PubMed ID: 699402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Simultaneous presence of antibodies against the glomerular basement membrane and anti-myeloperoxidase antibodies in 2 patients with rapidly progressive glomerulonephritis].
    Díaz Rodríguez C; Costero O; Torre A; De Alvaro F; Gil F; Picazo ML; Martínez-Ara J
    Nefrologia; 2002; 22(2):190-5. PubMed ID: 12085420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiglomerular basement membrane nephritis after solvent exposure.
    Kleinknecht D; Morel-Maroger L; Callard P; Adhémar JP; Mahieu P
    Arch Intern Med; 1980 Feb; 140(2):230-2. PubMed ID: 7352818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of anti-GBM-antibody positive rapidly progressive glomerulonephritis who was weaned from hemodialysis after combination therapy with steroid and plasmapheresis].
    Kitaura K; Asano K
    Nihon Jinzo Gakkai Shi; 2005; 47(8):887-92. PubMed ID: 16408434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of non anti-GBM-antibody mediated, rapidly progressive glomerulonephritis by plasmapheresis and immunosuppression.
    Müller GA; Seipel L; Risler T
    Klin Wochenschr; 1986 Mar; 64(5):231-8. PubMed ID: 3702282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-glomerular basement membrane disease in Auckland.
    Taylor DM; Yehia M; Simpson IJ; Thein H; Chang Y; de Zoysa JR
    Intern Med J; 2012 Jun; 42(6):672-6. PubMed ID: 22032242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapse in anti glomerular basement membrane antibody mediated crescentic glomerulonephritis.
    Wu MJ; Moorthy AV; Beirne GJ
    Clin Nephrol; 1980 Feb; 13(2):97-102. PubMed ID: 7363520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Goodpasture syndrome: treatment initiation with plasmapheresis before histologic diagnostic verification].
    Gartenschläger M; Lenci G; Schinzel H; Schweden F; Dienes HP; Weilemann LS
    Pneumologie; 1996 Nov; 50(11):764-8. PubMed ID: 9082444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [79-year-old patient with pulmorenal syndrome].
    Artunc F; Dorn C; Gehlen F; Büttner M; Amann K; Weyrich P; Heyne N; Wolf S
    Dtsch Med Wochenschr; 2010 Oct; 135(40):1982. PubMed ID: 20922641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case report of efficiency of double filtration plasmapheresis in treatment of Goodpasture's syndrome.
    Hajime N; Michiko A; Atsunori K; Tatsuo K; Yuko N; Naoki O; Katsuhiko S
    Ther Apher Dial; 2009 Aug; 13(4):373-7. PubMed ID: 19695077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracapillary glomerulonephritis type I with the coexistence of positive anti-GBM and p-ANCA antibodies.
    Toledo Perdomo K; Ortega Salas R; Pérez-Sáez MJ; Esquivias de Motta E; Espinosa Hernández M; López Andreu M; López Rubio F; Aljama García P
    Nefrologia; 2011; 31(1):113-5. PubMed ID: 21270926
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rapidly progressing glomerulonephritis].
    Iversen BM; Brekken K; Sund S; Christensen JA
    Tidsskr Nor Laegeforen; 1992 Aug; 112(18):2363-6. PubMed ID: 1412238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.